Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,370.00
(
-0.75%
)
Dow Jones
49,141.93
(
-0.34%
)
Brent Oil
104.01
(
-0.39%
)
Bitcoin
76,957.92
(
0.80%
)
News Focus
News Focus

Replies to post #224178 on Biotech Values

Replies to #224178 on Biotech Values
icon url

DewDiligence

03/19/19 11:58 AM

#224179 RE: rfj1862 #224178

None of the new HBV agents is in phase-3 yet. Moreover, all of the clinical programs for these agents are aiming for 2- or 3-drug combination regimens after initial testing on monotherapies.